Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Travelers' diarrhea: Clinical practice guidelines for pharmacists.

Fernandes HVJ, Houle SKD, Johal A, Riddle MS.

Can Pharm J (Ott). 2019 Jun 10;152(4):241-250. doi: 10.1177/1715163519853308. eCollection 2019 Jul-Aug. No abstract available.

2.

La diarrhée du voyageur.

Grindrod KA, Houle SKD, Fernandes H.

Can Fam Physician. 2019 Jul;65(7):487-490. French. No abstract available.

PMID:
31300434
Free Article
3.

Traveler's diarrhea.

Grindrod KA, Houle SKD, Fernandes H.

Can Fam Physician. 2019 Jul;65(7):483-486. No abstract available.

4.

Characteristics of patients vaccinated against influenza in physician offices versus pharmacies and predictors of vaccination location: a cross-sectional study.

Waite NM, Cadarette SM, Campitelli MA, Consiglio GP, Houle SKD, Kwong JC.

CMAJ Open. 2019 Jun 21;7(2):E421-E429. doi: 10.9778/cmajo.20180189. Print 2019 Apr-Jun.

5.

The International Pharmacists-as-Immunizers Partnership (IPIP)-Advancing Research on Pharmacist-Administered Immunizations Worldwide.

Violette RR, Houle SKD, Nissen LM, Waite NM.

Pharmacy (Basel). 2019 Jun 4;7(2). pii: E53. doi: 10.3390/pharmacy7020053.

6.

Will I lose my license for that? A closer look at Canadian disciplinary hearings and what it means for pharmacists' practice to full scope.

Foong EA, Grindrod KA, Houle SKD.

Can Pharm J (Ott). 2018 Aug 17;151(5):332-344. doi: 10.1177/1715163518790773. eCollection 2018 Sep-Oct.

7.

Getting it in the right spot: Shoulder injury related to vaccine administration (SIRVA) and other injection site events.

Bancsi A, Houle SKD, Grindrod KA.

Can Pharm J (Ott). 2018 Aug 17;151(5):295-299. doi: 10.1177/1715163518790771. eCollection 2018 Sep-Oct. No abstract available.

8.

Time to give up on expanded scope of practice.

Tsuyuki RT, Houle SKD, Okada H.

Can Pharm J (Ott). 2018 Aug 17;151(5):286. doi: 10.1177/1715163518793844. eCollection 2018 Sep-Oct. No abstract available.

9.

Uptake of Travel Health Services by Community Pharmacies and Patients Following Pharmacist Immunization Scope Expansion in Ontario, Canada.

Houle SKD, Kozlovsky K, Fernandes HVJ, Rosenberg-Yunger Z.

Pharmacy (Basel). 2019 Apr 13;7(2). pii: E35. doi: 10.3390/pharmacy7020035.

10.

The availability of pharmacists with Additional Prescribing Authorization in relation to the distribution of vulnerable populations - A cross-sectional study.

Alsabbagh MW, Houle SKD, Waite NM.

Res Social Adm Pharm. 2019 Apr 5. pii: S1551-7411(18)31001-5. doi: 10.1016/j.sapharm.2019.03.075. [Epub ahead of print]

PMID:
31000334
11.

Cost-utility analysis of offering a novel remunerated community pharmacist consultation service on influenza vaccination for seniors in Ontario, Canada.

Pullagura GR, Waite NM, Houle SKD, Violette R, Wong WWL.

J Am Pharm Assoc (2003). 2019 Jul - Aug;59(4):489-497.e1. doi: 10.1016/j.japh.2019.02.011. Epub 2019 Apr 9.

PMID:
30979576
12.

Remunerated patient care services and injections by pharmacists: An international update.

Houle SKD, Carter CA, Tsuyuki RT, Grindrod KA.

Can Pharm J (Ott). 2019 Jan 24;152(2):92-108. doi: 10.1177/1715163518811065. eCollection 2019 Mar-Apr. Review.

13.

Reply from the authors.

Tsuyuki RT, Okada H, Houle SKD.

Can Pharm J (Ott). 2018 Dec 17;152(1):9. doi: 10.1177/1715163518816044. eCollection 2019 Jan-Feb. No abstract available.

14.

Shoulder injury related to vaccine administration and other injection site events.

Bancsi A, Houle SKD, Grindrod KA.

Can Fam Physician. 2019 Jan;65(1):40-42. No abstract available.

15.
16.

The proportion, conditions, and predictors of emergency department visits that can be potentially managed by pharmacists with expanded scope of practice.

Alsabbagh MW, Houle SKD.

Res Social Adm Pharm. 2018 Dec 7. pii: S1551-7411(18)31014-3. doi: 10.1016/j.sapharm.2018.12.003. [Epub ahead of print]

PMID:
30545614
17.

Economic analysis of pharmacist-administered influenza vaccines in Ontario, Canada.

O'Reilly DJ, Blackhouse G, Burns S, Bowen JM, Burke N, Mehltretter J, Waite NM, Houle SK.

Clinicoecon Outcomes Res. 2018 Oct 24;10:655-663. doi: 10.2147/CEOR.S167500. eCollection 2018.

18.

Addressing professionalism in both formative and summative simulated patient care activities - Experiences with a discretionary deduction approach.

Houle SKD, Richard CL, Lillie E.

Curr Pharm Teach Learn. 2018 Sep;10(9):1243-1247. doi: 10.1016/j.cptl.2018.06.004. Epub 2018 Jun 28.

PMID:
30497628
19.

Do community pharmacist performance evaluations capture the modern pharmacist's role? Mapping competencies assessed in Canadian community pharmacy performance evaluation templates against the General Level Framework.

Chong IYM, Rosenthal MM, Manson KR, Houle SKD.

J Am Pharm Assoc (2003). 2018 Nov - Dec;58(6):638-642.e2. doi: 10.1016/j.japh.2018.08.006. Epub 2018 Sep 17.

PMID:
30237009
20.

Remunerated patient care services and injections by pharmacists: An international update.

Houle SKD, Carter CA, Tsuyuki RT, Grindrod KA.

J Am Pharm Assoc (2003). 2019 Jan - Feb;59(1):89-107. doi: 10.1016/j.japh.2018.07.002. Epub 2018 Sep 6.

PMID:
30195440
21.

Perceived preparedness for full-scope pharmacist services among recent Doctor of Pharmacy graduates from Ontario schools of pharmacy.

Waite NM, McCarthy L, Milne E, Hillier C, Houle SKD, Dolovich L.

J Am Pharm Assoc (2003). 2018 Nov - Dec;58(6):630-637. doi: 10.1016/j.japh.2018.06.016. Epub 2018 Aug 1.

PMID:
30077565
22.

Reply from authors.

Lamb SA, Al Hamarneh YN, Houle SKD, Leung AA, Tsuyuki RT.

Can Pharm J (Ott). 2018 May 4;151(3):158. doi: 10.1177/1715163518767828. eCollection 2018 May-Jun. No abstract available.

23.

Pharmacy travel health services: current perspectives and future prospects.

Houle SK.

Integr Pharm Res Pract. 2018 Mar 23;7:13-20. doi: 10.2147/IPRP.S142982. eCollection 2017. Review.

24.

Clinical outcomes and satisfaction with a pharmacist-managed travel clinic in Alberta, Canada.

Houle SKD, Bascom CS, Rosenthal MM.

Travel Med Infect Dis. 2018 May - Jun;23:21-26. doi: 10.1016/j.tmaid.2018.02.011. Epub 2018 Mar 2.

25.

Hypertension Canada's 2017 guidelines for diagnosis, risk assessment, prevention and treatment of hypertension in adults for pharmacists: An update.

Lamb SA, Al Hamarneh YN, Houle SKD, Leung AA, Tsuyuki RT.

Can Pharm J (Ott). 2017 Nov 29;151(1):33-42. doi: 10.1177/1715163517743525. eCollection 2018 Jan-Feb. No abstract available.

26.

CANImmunize: A digital tool to help patients manage their immunizations.

Houle SKD, Atkinson K, Paradis M, Wilson K.

Can Pharm J (Ott). 2017 May 26;150(4):236-238. doi: 10.1177/1715163517710959. eCollection 2017 Jul-Aug. No abstract available.

27.

Canadian pharmacists as immunizers: Addressing questions related to this new scope of practice.

Houle SKD.

Can J Public Health. 2017 Nov 9;108(4):e418-e420. doi: 10.17269/cjph.108.6119.

PMID:
29120315
28.

Pharmacists' perceptions of pay for performance versus fee-for-service remuneration for the management of hypertension through pharmacist prescribing.

Rosenthal MM, Desai N, Houle SKD.

Int J Pharm Pract. 2017 Oct;25(5):388-393. doi: 10.1111/ijpp.12330. Epub 2017 Jan 18.

PMID:
28097711
29.

Pay-for-performance remuneration for pharmacist prescribers' management of hypertension: A substudy of the RxACTION trial.

Houle SK, Charrois TL, McAlister FA, Kolber MR, Rosenthal MM, Lewanczuk R, Campbell NR, Tsuyuki RT.

Can Pharm J (Ott). 2016 Nov;149(6):345-351. Epub 2016 Oct 3.

30.

Hypertension Canada's 2016 Canadian Hypertension Education Program guidelines for pharmacists: An update.

Al Hamarneh YN, Houle SK, Padwal R, Tsuyuki RT.

Can Pharm J (Ott). 2016 Nov;149(6):337-344. Epub 2016 Oct 6. No abstract available.

31.

A randomized controlled study of practice facilitation to improve the provision of medication management services in Alberta community pharmacies.

Houle SK, Charrois TL, Faruquee CF, Tsuyuki RT, Rosenthal MM.

Res Social Adm Pharm. 2017 Mar - Apr;13(2):339-348. doi: 10.1016/j.sapharm.2016.02.013. Epub 2016 Mar 8.

PMID:
27017157
32.

The 2015 Canadian Hypertension Education Program (CHEP) guidelines for pharmacists: An update.

Houle SK, Padwal R, Poirier L, Tsuyuki RT.

Can Pharm J (Ott). 2015 Jul;148(4):180-6. doi: 10.1177/1715163515586847. Review. No abstract available.

33.

Randomized Trial of the Effect of Pharmacist Prescribing on Improving Blood Pressure in the Community: The Alberta Clinical Trial in Optimizing Hypertension (RxACTION).

Tsuyuki RT, Houle SK, Charrois TL, Kolber MR, Rosenthal MM, Lewanczuk R, Campbell NR, Cooney D, McAlister FA; RxACTION Investigators*.

Circulation. 2015 Jul 14;132(2):93-100. doi: 10.1161/CIRCULATIONAHA.115.015464. Epub 2015 Jun 10.

PMID:
26063762
34.

A cluster-randomized controlled knowledge translation feasibility study in Alberta community pharmacies using the PARiHS framework: study protocol.

Rosenthal MM, Tsuyuki RT, Houle SK.

Pilot Feasibility Stud. 2015 Jan 12;1:2. doi: 10.1186/2055-5784-1-2. eCollection 2015.

36.

Self-denigrating terms.

Houle SK, Grindrod KA.

Can Pharm J (Ott). 2014 Nov;147(6):328. doi: 10.1177/1715163514552645. No abstract available.

37.

Paying pharmacists for patient care: A systematic review of remunerated pharmacy clinical care services.

Houle SK, Grindrod KA, Chatterley T, Tsuyuki RT.

Can Pharm J (Ott). 2014 Jul;147(4):209-32. doi: 10.1177/1715163514536678. Review.

38.

The 2014 Canadian Hypertension Education Program (CHEP) guidelines for pharmacists: An update.

Houle SK, Padwal R, Poirier L, Tsuyuki RT.

Can Pharm J (Ott). 2014 Jul;147(4):203-8. doi: 10.1177/1715163514535341. No abstract available.

39.

Prescribing by pharmacists in Alberta and its relation to culture and personality traits.

Rosenthal MM, Houle SK, Eberhart G, Tsuyuki RT.

Res Social Adm Pharm. 2015 May-Jun;11(3):401-11. doi: 10.1016/j.sapharm.2014.09.004. Epub 2014 Sep 21.

PMID:
25315135
40.

Multidisciplinary approaches to the management of high blood pressure.

Houle SK, Chatterley T, Tsuyuki RT.

Curr Opin Cardiol. 2014 Jul;29(4):344-53. doi: 10.1097/HCO.0000000000000071. Review.

PMID:
25029452
41.

Response to letters about vitamin B12.

Kolber MR, Houle SK.

Can Fam Physician. 2014 Jun;60(6):522. No abstract available.

43.

A case study in mobilizing all pharmacy team members in the community setting: A clinical facilitation role for pharmacy technicians.

Houle SK, Rosenthal MM, Tsuyuki RT.

Can Pharm J (Ott). 2014 Mar;147(2):85-8. doi: 10.1177/1715163513513865. No abstract available.

44.

Oral vitamin B12: a cost-effective alternative.

Kolber MR, Houle SK.

Can Fam Physician. 2014 Feb;60(2):111-2. No abstract available.

46.

Abnormal vaginal bleeding following pharmacist prescribing of metformin leads to the detection of complex endometrial hyperplasia.

Lyster RL, Houle SK.

Ann Pharmacother. 2013 Nov;47(11):1581-3. doi: 10.1177/1060028013504385.

PMID:
24285770
47.

Publicly funded remuneration for the administration of injections by pharmacists: An international review.

Houle SK, Grindrod KA, Chatterley T, Tsuyuki RT.

Can Pharm J (Ott). 2013 Nov;146(6):353-64. doi: 10.1177/1715163513506369.

48.

The 2012-2013 Canadian Hypertension Education Program (CHEP) guidelines for pharmacists: An update.

Houle SK, Padwal R, Tsuyuki RT.

Can Pharm J (Ott). 2013 May;146(3):146-50. doi: 10.1177/1715163513487476. No abstract available.

49.

The validity of blood pressure kiosk validation studies: a systematic review.

Al Hamarneh YN, Houle SK, Chatterley P, Tsuyuki RT.

Blood Press Monit. 2013 Jun;18(3):167-72. doi: 10.1097/MBP.0b013e328360fb85. Review.

PMID:
23635486
50.

Public-use blood pressure machines in pharmacies for identification of undetected hypertension in the community.

Houle SK, Tsuyuki RT.

J Clin Hypertens (Greenwich). 2013 Apr;15(4):302. doi: 10.1111/jch.12061. Epub 2013 Jan 9. No abstract available.

Supplemental Content

Loading ...
Support Center